Case Report
Extensively Drug-Resistant Myroides odoratus in Critically Ill Patients: A Case Series and Literature Review
Table 1
Susceptibilities for M. odoratus isolates.
| | Case 1 | | Isolate #1—sputum drug | HD41 MIC (mcg/mL) | Interpretation | HD55 MIC (mcg/mL) | Interpretation | HD80 MIC (mcg/mL) |
| | Amikacin | >32 | R | — | — | — | | Aztreonam | >16 | R | — | — | — | | Cefepime | >16 | R | — | — | — | | Ceftazidime | >16 | R | — | — | — | | Ceftriaxone | >32 | R | — | — | — | | Ciprofloxacin | >2 | R | — | — | — | | Ertapenem | Unavailable | R | — | — | — | | Gentamicin | >8 | R | — | — | — | | Levofloxacin | 1 | R | — | — | — | | Piperacillin/tazobactam | >64/4 | R | — | — | — | | Tobramycin | >8 | R | — | — | — | | Trimethoprim/sulfamethoxazole | >2/38 | R | — | — | — | | Minocycline | — | — | ≤1 | S | — | | Ceftazidime/avibactam | — | — | >8/4 | — | — | | Ceftolozane/tazobactam | — | — | >8/4 | — | — | | Meropenem/vaborbactam | — | — | >16/8 | — | — | | Tigecycline | — | — | — | — | ≤1 |
| | Case 2 | | Isolate #2—wound drug | HD76 MIC (mcg/mL) | Interpretation | Isolate #3—blood HD84 MIC (mcg/mL) | Interpretation | | Amikacin | >32 | R | >32 | R | | Aztreonam | >16 | R | >16 | R | | Cefepime | >16 | R | >16 | R | | Ceftazidime | >16 | R | >16 | R | | Ceftriaxone | >32 | R | >32 | R | | Ciprofloxacin | >2 | R | >2 | R | | Ertapenem | Unavailable | R | Unavailable | R | | Gentamicin | >8 | R | >8 | R | | Levofloxacin | 1 | R | >4 | R | | Piperacillin/tazobactam | >64/4 | R | >64/4 | R | | Tobramycin | >8 | R | >8 | R | | Trimethoprim/sulfamethoxazole | >2/38 | R | >2/38 | R | | Minocycline | 0.064 | S | ≤1 | S | | Meropenem | >32 | R | — | — | | Tigecycline | — | — | 2 | — | | Moxifloxacin | 0.094 | — | — | — | | Eravacycline | — | — | 0.75 | — |
|
|
HD, hospital day.
|
